A dialysis facility in Grove City, PA. It ran an operating loss of 4.8% in FY25 on $1.3M of operating revenue. It held -587 days of cash on hand — an Astrelis calculation outside expected range, shown at the chart boundary and ranked in its pool. Operating margin declined from 4.5% in FY20 to -4.8% in FY25.
Operating margin · FY25
-4.8%
Astrelis calculation · as-filed inputs
▼ 6.2 pts vs FY24
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY25)
Days cash on hand · FY25
-587d
all sources
Astrelis calculation · as-filed inputs
▼ 41 days vs FY24
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY25)
Total operating revenue · FY25
$1.3M
Astrelis calculation · as-filed inputs
▼ $0.1M vs FY24
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY25)
Total margin · incl. nonoperating · FY25
-4.4%
Astrelis calculation · as-filed inputs
▼ 6.2 pts vs FY24
not ranked: no valid same-year pool for this metric (needs n ≥ 25 and ≥ 50% of the cohort's filers at FY25)
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gated
Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio computes only when every input is reported in the filing (otherwise its cell states which input is Not reported in source); a year whose balance sheet does not reconcile is labeled, and its derived ratios read Astrelis calculation unavailable. Not audited by Astrelis.
Operating margin
-4.8% (FY25)
Operating income ÷ total operating revenue
Astrelis calculation · HCRIS WS G-3
Total margin
-4.4% (FY25)
Net income ÷ total revenue incl. nonoperating
Astrelis calculation · HCRIS WS G-3
Days cash on hand
-587d (FY25)
Cash & investments ÷ daily operating expense
Astrelis calculation · HCRIS WS G / G-3
Current ratio
Astrelis calculation unavailable — the filed balance sheet does not reconcile as filed (statement values shown unchanged)
Total current assets ÷ current liabilities
Astrelis calculation · HCRIS WS G
Equity financing ratio
Astrelis calculation unavailable — the filed balance sheet does not reconcile as filed (statement values shown unchanged)
Total net assets ÷ total assets
Astrelis calculation · HCRIS WS G
Days in net patient A/R
Astrelis calculation unavailable — the filed balance sheet does not reconcile as filed (statement values shown unchanged)
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
Astrelis calculation · HCRIS WS G / G-3
$ in thousands
Line item
FY23
FY24
FY25
Patient revenue
1,257
1,425
1,305
Total operating revenue
1,257
1,425
1,305
Total operating expenses
1,485
1,405
1,368
Operating income
(228)
20
(62)
Operating margin %
-18.1%
+1.4%
-4.8%
Other non-operating, net
6
6
5
Net income
(222)
26
(57)
Net income %
-17.6%
+1.8%
-4.4%
— = Not reported in source for that year.
HCRIS CMS-265 cost report · $ thousands · FY20–FY25 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding
Display states.FY20 · Days cash on hand: -436 days — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (outside the 0–1,500-day expected range — a valid filing can produce this; the pool absorbs it)FY21 · Days cash on hand: -467 days — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (outside the 0–1,500-day expected range — a valid filing can produce this; the pool absorbs it)FY22 · Days cash on hand: -480 days — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (outside the 0–1,500-day expected range — a valid filing can produce this; the pool absorbs it)FY23 · Days cash on hand: -533 days — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (outside the 0–1,500-day expected range — a valid filing can produce this; the pool absorbs it)FY24 · Days cash on hand: -546 days — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (outside the 0–1,500-day expected range — a valid filing can produce this; the pool absorbs it)FY25 · Days cash on hand: -587 days — Astrelis calculation · outside expected range; shown at the chart boundary and included in peer statistics (outside the 0–1,500-day expected range — a valid filing can produce this; the pool absorbs it)
How it operates
quality & operational context · CMS public reporting
The metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by provenance class and public source; descriptive context only, never a ranking or adequacy claim. Provenance labels: Reported value is copied from the named public source; Astrelis calculation is a formula applied to unchanged reported inputs, with the formula shown; Illustrative estimate is a benchmark gap, multiplier, or scenario — never a measurement.
Quality star
1★
Reported value2026
CMS Dialysis Compare
Total treatments
3,889
Reported value2025
HCRIS CMS-265
Cost per treatment ($)
351.68
Astrelis calculation2025
HCRIS CMS-265
Net revenue per treatment ($)
335.64
Astrelis calculation2025
HCRIS CMS-265
Dialysis stations
12
Reported value2026
CMS Dialysis Facility Compare
Modalities offered
In-center hemodialysis, Peritoneal dialysis
Reported value2026
CMS Dialysis Facility Compare
Trajectory
Cost-report basis · 6 reporting years
Operating margin
Days cash on hand
State context
Grove City, PA
Located in Grove City, PA. County-level statistics: linkage not established— this record's county mapping is not verified in the resolved spine, and we never place a facility in a county by guesswork. State-level context appears here once a state aggregate layer lands.
A facility-specific dollar comparison cannot be calculated because a valid same-year peer pool was not reported. The report still includes all available facility measures, peer benchmarks, and a source-coverage inventory.
Report coverage: Standard Facility Benchmark. 10 of 10 facility measures available from public sources. Every declared facility measure is available for this record, benchmarked against its same-year peer pools. The refund guarantee stands: if we cannot deliver the published scope, you pay nothing.
The Board Briefing
Your facility and its world in 35+ board-ready pages, every measure benchmarked against its same-year peers.
$1,000delivered within 2 business days of invoice
Reservation: invoice after coverage confirmation. No payment is collected on this site.
